Hallux Valgus Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Hallux Valgus Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

“Delveinsight Business Research LLP”
DelveInsight’s “Hallux Valgus Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Hallux Valgus, historical and forecasted epidemiology as well as the Hallux Valgus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Hallux valgus, commonly known as a Bunion, is one of the most common progressive forefoot deformities across the globe. A bunion is basically a “bump” that develops at the joint of the big toe—the metatarsophalangeal (MTP) joint. The big toe is made up of two joints. The larger of the two is the MTP, where the first long bone of the foot (metatarsal) meets the first bone of the toe (phalanx). The therapy choices for bunions comprise self-care, numerous pain-relieving medications, medical devices, and the most important one, Surgery. Although, the kind of treatment suggested to the patient entirely depends upon the severity of the condition.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/hallux-valgus-market

Hallux Valgus Market

The Hallux Valgus market report also covers emerging drugs, current treatment practices, Hallux Valgus market share of the individual therapies, current and forecasted Hallux Valgus Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Hallux Valgus treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Hallux Valgus Market Key Facts

  • In the year 2017, the total prevalent case of Hallux Valgus was 172,039,751 in the 7MM. The United States, in 2017, accounted for nearly 41% of the total 7MM cases.

  • Among the EU-5 countries, the highest number of cases of Hallux Valgus were in Germany, i.e. 18,748,873 cases in the year 2017. 

  • Among the 7MM, the United Kingdom accounted for 14,374,384 cases in 2017.

  • Spain accounted for the least number of prevalent cases, i.e., 11,229,531 cases in 2017.

  • Japan accounted for about 16% of the total 7MM prevalent cases of Hallux Valgus in 2017.

Key Benefits of Hallux Valgus Market Report

  • Hallux Valgus market report provides an in-depth analysis of Hallux Valgus Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets, i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Hallux Valgus market report will help in developing business strategies by understanding the Hallux Valgus Market trends & developments, key players, and future market competition that will shape and drive the Hallux Valgus market in the upcoming years.

  • The Hallux Valgus market report covers Hallux Valgus current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Hallux Valgus market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Hallux Valgus Market

Hallux Valgus market size is expected to increase during the study period owing to the rise in the number of prevalent cases in the 7MM and the growth in the usage of current treatment options.

The Hallux Valgus market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Hallux Valgus market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Hallux Valgus market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Hallux Valgus Market Drivers – 

  • Availability of numerous treatment options

  • Increasing prevalence owing to increased use of tight, narrow fitted footwear majorly

Hallux Valgus Epidemiology

The Hallux Valgus epidemiology section covers insights about the historical and current Hallux Valgus patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Hallux Valgus Epidemiology Segmentation –

  • Total Prevalent cases

  • Total Diagnosed Prevalent cases

  • Gender-specific Prevalent cases

  • Total Treated cases

  • Total Severity specific cases

Hallux Valgus Drugs Uptake and Key Market Players

The Hallux Valgus Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hallux Valgus market or expected to get launched in the market during the study period. The analysis covers Hallux Valgus market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The dynamics of treatment for Hallux Valgus depend majorly on surgical procedures as they provide better and long-term relief to the patients. Several pain relief medications are being developed for post-surgical bunionectomy pain relief. Talking about the emerging situation, limited activity has been observed and the relevant current emerging therapies are focusing on symptomatic relief (i.e., pain relief) and not treating the actual underlying cause. At present few companies are diligently involved in the development of therapies.

Hallux Valgus Companies:
Trilliant Surgical
Nextremity Solutions
Wright medical
Treace Medical Concepts
Wright Medical Technology
Concentric Analgesics
Taiwan Liposome Company
And many others

Hallux Valgus Therapies covered in the report include:
And many more

Table of Content

1. Key Insights

2. Executive Summary 

3. Hallux Valgus Competitive Intelligence Analysis

4. Hallux Valgus Market Overview at a Glance

5. Hallux Valgus Disease Background and Overview

6. Hallux Valgus Patient Journey

7. Hallux Valgus Epidemiology and Patient Population

8. Hallux Valgus Treatment Algorithm, Current Treatment, and Medical Practices

9. Hallux Valgus Unmet Needs

10. Key Endpoints of Hallux Valgus Treatment

11. Hallux Valgus Marketed Products

12. Hallux Valgus Emerging Therapies

13. Hallux Valgus Seven Major Market Analysis

14. Attribute Analysis

15. Hallux Valgus Market Outlook (7 major markets)

16. Hallux Valgus Access and Reimbursement Overview

17. KOL Views on the Hallux Valgus Market.

18. Hallux Valgus Market Drivers

19. Hallux Valgus Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/hallux-valgus-market

Related Reports  –
Hallux Valgus Pipeline Insights
Hallux Valgus Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Hallux Valgus market.

Healthcare Blog By DelveInsight –
Substance Use Disorder Market
The Substance Use Disorder treatment market possesses challenges in terms of diagnosis, accessibility, and affordability of care. Apart from these the lack of continuous support also creates a treatment gap and hinders the healthcare outcome for the affected person. To address the therapeutics need in the Substance Use Disorder market, some of the major pharmaceutical and biotech companies such as Omeros Corporation, KemPharm, InterveXion Therapeutics, MediciNova, and others are actively involved in the development of therapies. To read more, visit: Substance Use Disorder Treatment Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/